Furthermore, genetic studies on epileptic patients are needed to discover potential genetic variants in WNK proteins that contribute to overactive WNK-SPAK/OSR1 signaling, in order to determine if this is a genetic risk factor for epilepsy. The gene discussed is STK39; the disease is epilepsy.